APA (7th ed.) Citation

CI, F., G, F., CB, F., & HC, F. (1992). Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer. Oncology, 49(6), 418. https://doi.org/10.1159/000227084

Chicago Style (17th ed.) Citation

CI, Falkson, Falkson G, Falkson CB, and Falkson HC. "Mitomycin C + High-dose Medroxyprogesterone Versus Cyclophosphamide+doxorubicin Plus Fluorouracil as First-line Treatment for Metastatic Breast Cancer." Oncology 49, no. 6 (1992): 418. https://doi.org/10.1159/000227084.

MLA (9th ed.) Citation

CI, Falkson, et al. "Mitomycin C + High-dose Medroxyprogesterone Versus Cyclophosphamide+doxorubicin Plus Fluorouracil as First-line Treatment for Metastatic Breast Cancer." Oncology, vol. 49, no. 6, 1992, p. 418, https://doi.org/10.1159/000227084.